CLINICAL PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF KETOBEMIDONE

被引：32

作者：

BONDESSON, U

ARNER, S

ANDERSON, P

BOREUS, LO

HARTVIG, P

机构：

[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM,SWEDEN

[2] NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN

[3] KAROLINSKA HOSP,DEPT ANESTHESIOL,S-10401 STOCKHOLM,SWEDEN

[4] UNIV UPPSALA HOSP,S-75014 UPPSALA,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1980年 / 17卷 / 01期

关键词：

D O I：

10.1007/BF00561676

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：45 / 50

页数：6

共 23 条

[1]

BERKOWITZ BA, 1975, CLIN PHARMACOL THER, V17, P629

[2]

BERNSMEIER A, 1950, MED WELT, V1, P1491

[3]

BERNSTEIN A, 1949, SCHWEIZ MED WSCHR, V79, P1159

[4]

BLANKE K, 1950, Med Klin, V45, P1171

[5] MASS FRAGMENTOGRAPHIC METHOD FOR THE DETERMINATION OF KETOBEMIDONE IN PLASMA [J].

BONDESSON, U ;

HARTVIG, P .

JOURNAL OF CHROMATOGRAPHY, 1979, 179 (01) :207-212

[6]

BRUNK SF, 1974, CLIN PHARMACOL THER, V16, P51

[7]

BURNS JJ, 1955, J PHARMACOL EXP THER, V114, P289

[8]

DUNKERLEY R, 1976, CLIN PHARMACOL THER, V20, P546

[9]

EDDY N B, 1957, Bull World Health Organ, V17, P569

[10]

EHRNEBO M, 1977, CLIN PHARMACOL THER, V22, P888

← 1 2 3 →